Literature DB >> 31991015

Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.

Leonard Naymagon1, Douglas Tremblay1, John Mascarenhas1.   

Abstract

BACKGROUND: The standard diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH) include hyperferritinemia to >500 ng/mL. This ferritin threshold is based on pediatric data, and evidence for its application among adults with secondary HLH is lacking. OBJECTIVE AND METHODS: We conducted a retrospective study assessing the relationship between extreme hyperferritinemia and adult secondary HLH at our institution. All adult inpatients seen over a 10-year period, with serum ferritin >5000 ng/mL, were included.
RESULTS: Among 1055 patients with serum ferritin >5000 ng/mL, there were 69 cases of HLH (HLH prevalence of 6.5%). Mean ferritin among HLH patients was 70 398 ng/mL (SD 122 908), median 40 019 ng/mL (IQR 16 051-68 326). The prevalence of HLH only reached 50% as serum ferritin approached 90 000 ng/mL. A variety of conditions were contributory to hyperferritinemia, most commonly bacterial sepsis (33%), hematologic malignancy (29%), renal failure (24%), and liver injury (18%). The optimal cutoff ferritin for diagnosis of HLH was 16 000 ng/mL (sensitivity 79.4%, specificity 79.2%, PPV 20.9%, and NPV 98.2%).
CONCLUSIONS: The threshold ferritin levels used in diagnostic criteria for adult secondary HLH are too low to be clinically relevant, and efforts should be undertaken to revise them upward. Similar reappraisals should be taken of the other criteria used to diagnose adult HLH.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Hemophagocytic lymphohistiocytosis (HLH); diagnosis; ferritin; hyperferritinemia

Mesh:

Substances:

Year:  2020        PMID: 31991015     DOI: 10.1111/ejh.13391

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Clinical analysis and a novel risk predictive nomogram for 155 adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Mengxin Lu; Yanghao Xie; Xiaoxu Guan; Ming Wang; Lin Zhu; Shen Zhang; Qin Ning; Meifang Han
Journal:  Ann Hematol       Date:  2021-05-12       Impact factor: 3.673

2.  An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.

Authors:  Adi Zoref-Lorenz; Jun Murakami; Liron Hofstetter; Swaminathan Iyer; Ahmad S Alotaibi; Shehab Fareed Mohamed; Peter G Miller; Elad Guber; Shiri Weinstein; Joanne Yacobovich; Sarah Nikiforow; Benjamin L Ebert; Adam Lane; Oren Pasvolsky; Pia Raanani; Arnon Nagler; Nancy Berliner; Naval Daver; Martin Ellis; Michael B Jordan
Journal:  Blood       Date:  2022-02-17       Impact factor: 25.476

3.  Natural-killer cell cytotoxicity as a diagnostic and prognostic marker for adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective phase II observational study.

Authors:  Eun-Jee Oh; Jae-Ho Yoon; Ki Hyun Park; Hyun Joo Bae; So Jeong Yun; Gi June Min; Sung-Soo Park; Silvia Park; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Kyungja Han; Jong Wook Lee
Journal:  Ther Adv Hematol       Date:  2021-05-31

Review 4.  Therapeutic potential of induced iron depletion using iron chelators in Covid-19.

Authors:  Punnoth Poonkuzhi Naseef; Muhammed Elayadeth-Meethal; K T Mohammed Salim; A Anjana; C Muhas; K Abdul Vajid; Mohamed Saheer Kuruniyan
Journal:  Saudi J Biol Sci       Date:  2021-12-13       Impact factor: 4.052

5.  An Unusual Presentation of Glandular Fever.

Authors:  Dominic Worku; Li Hui Chang; Ian Blyth
Journal:  Case Rep Infect Dis       Date:  2022-03-18

6.  Cytomegalovirus pneumonitis-induced secondary hemophagocytic lymphohistiocytosis and SIADH in an immunocompetent elderly male literature review.

Authors:  Sachin M Patil; Phillip Paul Beck; Tarang Pankaj Patel; Michael P Hunter; Jeremy Johnson; Bran Andres Acevedo; William Roland
Journal:  IDCases       Date:  2020-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.